MetaCap

Who Owns Atrium Therapeutics Stock?

NASDAQ: RNAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

6.92-0.06 (-0.86%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
65.86%
Institutional holders
200
  • Institutions 65.9%
  • Insiders 3.3%
  • Public and other 30.8%

Who owns Atrium Therapeutics stock?

Institutional investors own about 65.9% of Atrium Therapeutics's shares, spread across 200 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 3.30% of RNA.

The largest institutional holders are Sessa Capital IM, L.P. (6.95%), Blackrock Inc. (5.65%) and Vanguard Capital Management LLC (3.38%). Together, the top 10 institutions control 32.2% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their RNA positions and 6 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of RNA

Atrium Therapeutics top institutional holders
InstitutionShares% HeldChange
Sessa Capital IM, L.P.1.50M6.95%0.0%
Blackrock Inc.1.22M5.65%-15.8%
Vanguard Capital Management LLC730.03K3.38%-0.1%
Price (T.Rowe) Associates Inc640.03K2.97%-56.5%
O'Connor Alternative Investments LLC559.14K2.59%-6.3%
Bracebridge Capital, LLC524.48K2.43%+276.7%
TIG Advisors, LLC506.93K2.35%-9.7%
Bank of America Corporation467.82K2.17%+252.2%
Two Sigma Investments, LP427.38K1.98%+23.7%
Geode Capital Management, LLC379.82K1.76%-1.8%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of RNA

Atrium Therapeutics top fund holders
FundShares% Held
T. Rowe Price Health Sciences Fund, Inc.566.43K2.63%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund518.42K2.40%
T. Rowe Price New Horizons Fund, Inc.443.26K2.05%
iShares Trust-iShares Russell 2000 ETF379.26K1.76%
TR PRICE-Price (T.Rowe) New Horizons Trust206.51K0.96%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund188.63K0.87%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund154.18K0.71%
NexPoint Funds I-NexPoint Merger Arbitrage Fund135.14K0.63%
iShares Trust-iShares Russell 2000 Growth ETF99.38K0.46%
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund82.34K0.38%

Frequently asked questions

Who is the largest shareholder of Atrium Therapeutics?

Sessa Capital IM, L.P. is the largest institutional shareholder of RNA, owning 6.95% of shares outstanding (1.50M shares) as of its latest 13F filing.

What percentage of Atrium Therapeutics is owned by institutions?

Institutions own about 65.9% of RNA shares and 68.1% of the public float.

How much of Atrium Therapeutics do insiders own?

Insiders, such as officers and directors, own about 3.30% of RNA shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related